In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis

Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study

(2011) Marjeta Terčelj et al.   Environmental Health

Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro

(2011) Sanja Stopinšek et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Antifungal medication is efficient in the treatment of sarcoidosis

(2011) Marjeta Terčelj et al.   Therapeutic Advances in Respiratory Disease

Airborne enzyme measurements to detect indoor mould exposure

(2010) Ragnar Rylander et al.   JOURNAL OF ENVIRONMENTAL MONITORING

Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers

(2010) Riccardo Muzzarelli   Marine Drugs

Immunologic Response of Sarcoidosis

(2010) Gernot Zissel et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Ex vivo cytokine release reflects sensitivity to occupational endotoxin exposure

(2009) L. A. M. Smit et al.   EUROPEAN RESPIRATORY JOURNAL

Chitotriosidase activity in sarcoidosis and some other pulmonary diseases

(2009) Marjeta Terčelj et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

The Immunology of Sarcoidosis

(2008) Alicia K. Gerke et al.   CLINICS IN CHEST MEDICINE

Intracellular cytokine profiles and T cell activation in pulmonary sarcoidosis

(2008) T.A. Hill et al.   CYTOKINE

Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building

(2008) A. S. Laney et al.   INDOOR AIR

Moldy environments and toxic pneumonitis

(2008) R Rylander et al.   TOXICOLOGY AND INDUSTRIAL HEALTH

Microbial antigen treatment in sarcoidosis – A new paradigm?

(2007) Marjeta Terčelj et al.   MEDICAL HYPOTHESES

Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis

(2007) Shin-ichi Nureki et al.   RESPIRATORY MEDICINE